Literature DB >> 1392424

Reduced bone mineral density and low parathyroid hormone levels in patients with the adult form of hypophosphatasia.

C Wüster1, R Ziegler.   

Abstract

Hypophosphatasia is a heritable metabolic bone disease with characteristically reduced levels of alkaline phosphatase (ALP) in the blood, liver, kidney and bone. ALP levels are normal in the intestine and placenta. About 300 patients have been reported so far in the literature. Three kindreds with 52 known subjects are described here, whereby 12 subjects could be examined osteologically. Four subjects were patients and had clinical signs of the disease: spontaneous fractures of the metatarsals or femora and low ALP serum levels ranging between 8 and 23 U/l (normal range 40-170 U/l). Four other members without fractures had reduced ALP levels; they might be carriers of the disease and develop symptoms later in life. The four remaining subjects had normal ALP levels and no signs of the disease. Serum levels of intact parathyroid hormone (iPTH) were found to be in the lower normal range and serum calcium levels in the upper normal range. There was a significant (P less than 0.05) negative correlation between iPTH and serum calcium levels (r = -0.78). Urinary calcium excretion was increased in 3 subjects with fractures. 25-OH-D3 levels were increased in 6 of 8 subjects without any treatment. The bone mineral density (BMD) was measured using dual X-ray absorptiometry of the lumbar spine, representing mainly trabecular bone, and single-photon absorptiometry of the forearm, measuring mainly cortical bone. Z-scores of the spinal bone mass ranged between 0.38 and -1.95 SD; Z-scores of the forearm bone mass ranged between 0.53 and -2.47 SD with the lowest values in patients with fractures.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1392424     DOI: 10.1007/bf00184792

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  15 in total

1.  Hypophosphatasia.

Authors:  D FRASER
Journal:  Am J Med       Date:  1957-05       Impact factor: 4.965

2.  Hypophosphatasia; a new developmental anomaly.

Authors:  J C RATHBUN
Journal:  Am J Dis Child       Date:  1948-06

3.  Hyperparathyroidism in an elderly adult with hypophosphatasia.

Authors:  F H Faas; C L Wadkins; J S Daniels; G R Davis; W J Carter; J O Wynn
Journal:  Clin Orthop Relat Res       Date:  1974-06       Impact factor: 4.176

4.  Infantile hypophosphatasia--linkage with the RH locus.

Authors:  B N Chodirker; J A Evans; M Lewis; G Coghlan; E Belcher; S Philipps; L E Seargeant; C Sus; C R Greenberg
Journal:  Genomics       Date:  1987-11       Impact factor: 5.736

5.  Hyperparathyroidism and infantile hypophosphatasia: effect of prednisone and vitamin K therapy.

Authors:  N M Wolfish; H Heick
Journal:  J Pediatr       Date:  1979-12       Impact factor: 4.406

6.  Circulating vitamin D metabolite levels in hypophosphatasia.

Authors:  M P Whyte; Y Seino
Journal:  J Clin Endocrinol Metab       Date:  1982-07       Impact factor: 5.958

7.  Management of femoral fractures and pseudofractures in adult hypophosphatasia.

Authors:  J D Coe; W A Murphy; M P Whyte
Journal:  J Bone Joint Surg Am       Date:  1986-09       Impact factor: 5.284

8.  A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia.

Authors:  M J Weiss; D E Cole; K Ray; M P Whyte; M A Lafferty; R A Mulivor; H Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

9.  Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assay.

Authors:  E Blind; H Schmidt-Gayk; S Scharla; D Flentje; S Fischer; U Göhring; W Hitzler
Journal:  J Clin Endocrinol Metab       Date:  1988-08       Impact factor: 5.958

10.  Heterogeneity of adult hypophosphatasia. Report of severe and mild cases.

Authors:  R S Weinstein; M P Whyte
Journal:  Arch Intern Med       Date:  1981-05
View more
  4 in total

1.  Clinical, radiographic and biochemical characteristics of adult hypophosphatasia.

Authors:  T Schmidt; H Mussawy; T Rolvien; T Hawellek; J Hubert; W Rüther; M Amling; F Barvencik
Journal:  Osteoporos Int       Date:  2017-05-25       Impact factor: 4.507

Review 2.  Proposing a clinical algorithm for better diagnosis of hypophosphatasia in resource-limiting situations.

Authors:  Sreyanko Sadhukhan; Poonam Mehta; Singh Rajender; Sushil Kumar Gupta; Naibedya Chattopadhyay
Journal:  Osteoporos Int       Date:  2022-07-01       Impact factor: 4.507

Review 3.  Hypophosphatasia: an overview of the disease and its treatment.

Authors:  M L Bianchi
Journal:  Osteoporos Int       Date:  2015-08-06       Impact factor: 4.507

Review 4.  Alkaline Phosphatase Replacement Therapy.

Authors:  Maria Luisa Bianchi; Silvia Vai
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.